Published in J Exp Med on February 01, 1973
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells. Infect Immun (1983) 1.23
Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation. Clin Exp Immunol (1974) 1.11
Hapten-specific stimulation of secondary B cells independent of T cells. J Exp Med (1973) 1.10
In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect Immun (1984) 1.07
T and B cell in hapten-specific carrier-determined tolerance. J Exp Med (1975) 1.03
In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infect Immun (1982) 0.95
Antigen receptors on murine T lymphocytes in contact sensitivity. III. Mechanism of negative feedback regulation by auto-anti-idiotypic antibody. J Exp Med (1982) 0.93
Cells involved in the in vitro stimulation by DNP-carrier complexes of in vivo primed mouse spleen cells. Immunology (1974) 0.91
Antibody formation in the mouse induced by hapten-carrier complexes. Immunology (1975) 0.90
Cell co-operation and hapten--carrier complexes. Immunology (1975) 0.83
Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates. J Clin Invest (1975) 0.82
Interaction of subpopulations of murine lymph node lymphocytes in antigen-induced [14C]-thymidine incorporation: T and B cell synergy in the response to antigen. Immunology (1979) 0.78
Carrier-specific recognition for induction of secretory IgA anamnestic antibody responses. Immunology (1987) 0.77
Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med (1969) 18.89
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev (1969) 6.39
Surface antigenic markers for distinguishing T and B lymphocytes in mice. Transplant Rev (1971) 6.38
Chemical and serological studies with an iodine-containing synthetic immunological determinant 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and related compounds. Immunology (1966) 4.08
Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50
Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med (1972) 3.00
Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology (1969) 2.71
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
The elusive T cell receptor. Transplant Rev (1972) 2.14
Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten. J Exp Med (1971) 2.02
Hapten competition and the nature of cell-cooperation in the antibody response. Proc R Soc Lond B Biol Sci (1971) 1.85
Immunoglobulin determinants on mouse lymphocytes. J Immunol (1971) 1.63
Ability of CBA mice to produce anti-idiotypic sera to 5563 myeloma protein. Nature (1970) 1.46
Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol (1972) 1.43
The expression of immunoglobulin determinants on the surface of antigen-binding lymphoid cells in mice. I. An analysis of light and heavy chain restrictions on individual cells. Eur J Immunol (1971) 1.40
Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30
Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18
Mechanism of action of antilymphocyte serum. Fed Proc (1970) 1.15
Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med (1966) 10.03
Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev (1969) 6.39
Corticosteroids and lymphoid cells. N Engl J Med (1972) 5.69
Immunocompetence of transferred thymus-marrow cell combinations. J Immunol (1966) 4.52
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Hydrocortisne resistance of graft vs host activity in mouse thymus, spleen and bone marrow. J Immunol (1970) 2.83
Thymus-marrow immunocompetence. V. Hydrocortisone-resistant cells and processes in the hemolytic antibody response of mice. J Exp Med (1971) 2.46
Electroimmunodiffusion (EID): a simple, rapid method for quantitation of immunoglobulins in dilute biological fluids. J Lab Clin Med (1967) 2.37
Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol (1982) 2.36
Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells". J Immunol (1974) 2.25
Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance. J Immunol (1976) 2.22
Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J Immunol (1974) 2.18
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med (1979) 2.09
Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science (1970) 2.02
Demonstration of heavy and light chain antigenic determinants on the cell-bound receptor for antigen. Similarities between membrane-attached and humoral antibodies produced by the same cell. J Exp Med (1970) 2.01
Tolerance and contact sensitivity to DNFA in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity. J Immunol (1978) 1.92
Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72
How corticosteroids work. J Allergy Clin Immunol (1975) 1.70
The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. J Immunol (1976) 1.68
Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells. J Lab Clin Med (1971) 1.66
The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells. J Immunol (1983) 1.52
Site of action of cortisol in cellular immunity. J Immunol (1973) 1.46
Detection of gamma A antibody-releasing cells to erythrocyte and lipopolysaccharide antigens. J Immunol (1968) 1.43
Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol (1972) 1.43
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Human thymus cell cultures-evidence for two functional populations. Proc Soc Exp Biol Med (1966) 1.36
Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med (1985) 1.34
Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. J Immunol (1983) 1.34
Suppressor T cell mechanisms in contact sensitivity. I. Efferent blockade by syninduced suppressor T cells. J Immunol (1978) 1.31
Migration of antibody-forming cells and antigen-sensitive precursors between spleen, thymus and bone marrow. Immunology (1968) 1.27
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Serum immunoglobulins in rheumatoid arthritis. J Lab Clin Med (1966) 1.25
Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol (1985) 1.24
Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells. Infect Immun (1983) 1.23
Tolerance and contact sensitivity to DNFB in mice. V. Induction of tolerance with DNP compounds and with free and membrane-associated DNFB. J Immunol (1976) 1.22
H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization. J Exp Med (1977) 1.20
Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node. J Immunol (1974) 1.19
Regulation of cell mediated immunity by antibodies: possible role of anti-receptor antibodies in the regulation of contact sensitivity to DNFB in mice. J Immunol (1979) 1.19
Soluble factors in tolerance and contact sensitivity to DNFB in mice. II. Genetic requirements for suppression of contact sensitivity by soluble suppressor factor. J Immunol (1977) 1.19
Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB. Cold Spring Harb Symp Quant Biol (1977) 1.19
Serum immunoglobulin measurement during the first year of life and in immunoglobulin-deficiency states. J Pediatr (1966) 1.18
Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18
Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. J Immunol (1976) 1.16
Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol (1983) 1.15
Inhibition of antibody production and acquired immunologic tolerance by actinomycin. J Immunol (1965) 1.12
Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J Immunol (1974) 1.04
Thymus-marrow immunocompetence. IV. The growth and immunocompetence of transferred marrow, thymus, and spleen cells in parent and F1 hybrid mice. Transplantation (1969) 1.04
Age-related changes in cell-mediated immunity in BALB/C mice. J Immunol (1975) 1.03
Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin. J Invest Dermatol (1975) 1.02
Antigen receptors on murine T lymphocytes in contact sensitivity. I. Functional inhibition of effector T cells by monovalent 2,4-dinitrophenol: implication for a two-receptor model. J Exp Med (1981) 1.02
Changes in serum immunoglobulin and complement levels following renal homotransplantation. Transplantation (1970) 1.02
Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells. J Immunol (1982) 1.01
Quantitation of immunoglobulins in cerebrospinal fluid. Arch Neurol (1966) 1.01
Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells". J Immunol (1986) 1.01
Helicobacter pylori inhibits gastric cell cycle progression. Microbes Infect (2000) 1.00
Isolated severe gamma A deficiency: immunoglobulin levels, clinical disorders, and chromosome studies. J Lab Clin Med (1970) 1.00
The response of cultured human thymus cells to phytohemagglutinin. J Immunol (1968) 0.99
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Delayed hypersensitivity to herpes simplex virus: murine model. Infect Immun (1982) 0.99
Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics (1970) 0.97
Amyloid-associated muscle pseudohypertrophy. Arch Neurol (1982) 0.97
Bone marrow T cells. II. Thymic dependency. Cell Immunol (1974) 0.97
Suppressor T cell mechanisms in contact sensitivity. II. Afferent blockade by alloinduced suppressor T cells. J Immunol (1978) 0.96
Cortisol inhibition of immunologic activity in guinea pig alveolar cells. Int Arch Allergy Appl Immunol (1974) 0.96
Hypogammaglobulinemia, primary and secondary: immunoglobulin levels (gamma-G, gamma-A, gamma-M) in one hundred and twenty-five patients. J Allergy (1966) 0.95
Vasculitis in chronic urticaria. J Allergy Clin Immunol (1980) 0.95
Anti-immunoglobulin stimulation of murine lymphocytes. V. Age-related decline in Fc receptor-mediated immunoregulation. J Immunol (1978) 0.95
Cell-cell interactions in antibody production. Prog Allergy (1972) 0.95
Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. Surgery (1984) 0.95
Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol (1985) 0.95
Salivary immunoglobulin and albumin: development during the newborn period. J Pediatr (1968) 0.94
Increased proliferative response of human peripheral blood lymphocytes to anti-immunoglobulin antibodies in elderly people. Clin Immunol Immunopathol (1978) 0.93
Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol (1977) 0.93
Antigen receptors on murine T lymphocytes in contact sensitivity. III. Mechanism of negative feedback regulation by auto-anti-idiotypic antibody. J Exp Med (1982) 0.93